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Abstract
Background: Although high-throughput microarray based molecular diagnostic technologies show a great
promise in cancer diagnosis, it is still far from a clinical application due to its low and instable sensitivities and
specificities in cancer molecular pattern recognition. In fact, high-dimensional and heterogeneous tumor profiles
challenge current machine learning methodologies for its small number of samples and large or even huge
number of variables (genes). This naturally calls for the use of an effective feature selection in microarray data
classification.
Methods: We propose a novel feature selection method: multi-resolution independent component analysis (MICA)
for large-scale gene expression data. This method overcomes the weak points of the widely used transform-based
feature selection methods such as principal component analysis (PCA), independent component analysis (ICA), and
nonnegative matrix factorization (NMF) by avoiding their global feature-selection mechanism. In addition to
demonstrating the effectiveness of the multi-resolution independent component analysis in meaningful biomarker
discovery, we present a multi-resolution independent component analysis based support vector machines (MICA-
SVM) and linear discriminant analysis (MICA-LDA) to attain high-performance classifications in low-dimensional
spaces.
Results: We have demonstrated the superiority and stability of our algorithms by performing comprehensive
experimental comparisons with nine state-of-the-art algorithms on six high-dimensional heterogeneous profiles
under cross validations. Our classification algorithms, especially, MICA-SVM, not only accomplish clinical or near-
clinical level sensitivities and specificities, but also show strong performance stability over its peers in classification.
Software that implements the major algorithm and data sets on which this paper focuses are freely available at
https://sites.google.com/site/heyaumapbc2011/.
Conclusions: This work suggests a new direction to accelerate microarray technologies into a clinical routine
through building a high-performance classifier to attain clinical-level sensitivities and specificities by treating an
input profile as a ‘profile-biomarker’. The multi-resolution data analysis based redundant global feature suppressing
and effective local feature extraction also have a positive impact on large scale ‘omics’ data mining.
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With the rapid developments in genomics, high-throughput
microarray pattern analysis shows a great potential in
cancer diagnosis for its efficiency and cost-effectiveness [1].
However, such a promising technology remains an impor-
tant research field rather than an applicable clinical-routine.
Aside intrinsic factors from microarray profiling technolo-
gies, a key issue preventing it from becoming a clinical
paradigm is that the relatively low even poor sensitivities
and specificities obtained from current pattern recognition
methodologies are inadequate to provide a robust clinical
support. Moreover, some pattern classification methods
may perform reasonably well in some data sets but fail
badly in others. Although there is an urgent need in clinical
cancer research to develop high-performance pattern
recognition methods in gene expression analysis, it is still a
challenge in machine learning to attain high-accuracy clas-
sification for the special characteristics of gene expression
profiles.
A gene expression profile can be represented by a p×n
matrix after preprocessing, each column of which repre-
sents gene expression values of all biological samples at
a gene; each row of which represents gene expression
values of a single biological sample across a genome.
The total number of genes is in the order of 10
3~10
4,
and the total number of biological samples is on the
magnitude of tens or hundreds. Since the number of
variables (genes) is much greater than the number of
samples (observations), some traditional pattern recogni-
tion methods (e.g., fisher discriminant analysis) may
have instable solutions and lead to a low or poor classi-
fication performance. Alternatively, although there are a
large number of genes in a profile, only a small portion
of them have meaningful contributions to data varia-
tions. In addition, the high-dimensional data are not
noise-free because preprocessing algorithms may not
remove systematic noise contained in raw data comple-
tely. Obviously, the data redundancy and noise may
inevitably affect the discriminative power of the classifi-
cation algorithms applied to microarray data.
It is clear that feature selection play a critical role in
gene expression analysis to decrease dimensionalities,
remove noise, and extract meaningful features before
performing classification. Feature selection algorithms
usually can be categorized into three types: statistical
test-based (e.g., two-sample t-tests), wrapper-based (e.g.,
SVM-based wrappers) [2], and transform-based feature
selections. The transform-based feature selection may be
mostly used data reduction techniques for their popular-
ity and efficiency. They include principal component
analysis (PCA) [3], independent component analysis
(ICA) [4], nonnegative matrix factorization (NMF) [5,6],
etc, and their different extensions [7,8].
However, these transform-based feature selection algo-
rithms are generally good at selecting global features
instead of local features. The global and local features con-
tribute to the global and local characteristics of data and
interpret global and local behavior of data respectively.
Statistically, the global features consist of high-frequency
signals and the local features consist of low-frequency
signals. Unlike the global features, the local features are
difficult to extract for most feature-selection algorithms,
because the low-frequency signals have a lower likelihood
to get involved in inferring the ‘new’ low-dimensional
data, which are generally the linear combinations of all
input variables, than the high-frequency signals. Finally,
the low dimensional data obtained from the traditional
feature selection methods may miss some local data char-
acteristics described by the local features. For example,
P C Ai sb y - n a t u r eag l o b a lf e a ture selection algorithm:
each principal component contains some levels of global
characteristics of data and receives contributions from all
input variables in the linear combinations. In addition,
changes in one variable will inevitably affect all loading
vectors globally. However, local features may be a key to
attaining high-performance gene expression pattern classi-
fication for its subtle data behavior capturing. For exam-
ple, some benign tumor samples may display very similar
global characteristics with malignant tumor samples
but with different local characteristics. To attain high-
performance diagnosis, it is essential to capture local data
characteristics to distinguish these samples with similar
global characteristics.
The main reason for these algorithms’ global-feature
selection mechanism is because they all are single-
resolution feature selection methods, where all features
are indistinguishably displayed in a single-resolution
despite the nature of their frequencies. It inevitably
causes global features more likely to be selected than
local features and prevents effective local data-character-
istics capturing. Mathematically, all variables of the
input data are involved in the linear combinations to
compute principal components in PCA, independent
components in ICA, and basis vectors in NMF respec-
tively. Such a global feature selection mechanism will
prevent high-accuracy genomic pattern recognition in
the following classification because only the features
interpreting global characteristics are involved in train-
ing a learning machine (e.g., SVM). The redundant glo-
bal features may inevitably decrease the generalization
of the learning machine and increase the risk of misclas-
sifications or over-fitting. Finally, the learning machines
integrated with the global feature-selection algorithms
will display instabilities in classifications.
To avoid the global feature selection mechanism, it is
desirable to distinguish (e.g., sort) features according to
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which makes the high-frequency signals dominate the
feature selection and the low-frequency signals lose
opportunities. A discrete wavelet transform (DWT) [9]
can hierarchically organize data in a multi-resolution
way by low and high pass filters. The low (high)-pass fil-
ters only pass low (high)-frequency signals but attenuate
signals with frequencies higher (lower) than a cutoff fre-
quency. Finally, the DWT coefficients at the coarse
levels capture global features of the input signals and
the coefficients at the fine levels capture local features
of the signals, i.e., the low-frequency and high-frequency
signals are represented by coefficients in the coarse and
fine resolutions respectively. Obviously, the global fea-
ture selection mechanism can be relatively easy to over-
come after such a ‘multi-resolution feature separation’,
by selectively extracting local features and filtering
redundant global features.
In this study, we propose a novel multi-resolution
independent component analysis (MICA) to conduct
effective feature selections for high dimensional hetero-
geneous gene expression data. Then, a multi-resolution
independent component analysis based support vector
machines (MICA-SVM) are proposed to achieve a high-
performance gene expression pattern prediction. We
demonstrate its superiority and stability by comparing it
with existing state-of-the-art peers on six heterogeneous
microarray profiles, in addition to extending MICA to
linear discriminant analysis (MICA-LDA). We also
develop a MICA-based filter-wrapper biomarker discov-
ery algorithm to further demonstrate the novel feature
selection algorithm’s effectiveness in biomarker captur-
ing. Finally, we discuss potential extensions on the
multi-resolution independent component analysis in
microarray based molecular diagnosis and conclude this
paper.
Methods
Multi-resolution independent component analysis is
b a s e do nt h ed i s c r e t ew a v e l e tt r a n s f o r m( D W T )a n d
independent component analysis (ICA). A discrete
wavelet transform decomposes input data in a multi-
resolution form by using a wavelet and scaling function.
The coefficients at the coarse and fine levels describe
the global and local behavior of data respectively. Math-
ematically, DWT is equivalent to multiplying the input
data by a set of orthogonal matrices block-wisely. On
the other hand, ICA seeks to represent input data as the
linear combination of a set of statistically independent
components by minimizing their mutual information.
Theoretically, it is equivalent to inverting the central
limit theorem (CLT) by searching maximally non-
normal projections of the original data distribution.
More information about the DWT and ICA methods
can be found in [4,9].
Multi-resolution independent component analysis
The goal of the multi-resolution independent compo-
nent analysis is to seek the statistically independent
genomic patterns from a meta-profile computed by sup-
pressing the coarse level coefficients (global features)
and maintaining the fine level coefficients (local fea-
tures) in the DWT of an input profile. As an approxi-
mation of the high dimensional input profile, the
derived meta-profile captures almost all local features
and keeps the most important global features. Unlike
independent components in the classic ICA that are
mainly retrieved from the global features for their high
frequencies, the independent components calculated by
our proposed MICA method are statistically indepen-
dent signals, which contain contributions from almost
all local features and the most important global features.
As such, the latter is more representative in revealing
the latent data structure than the former. Moreover, the
redundant global feature suppressing brings MICA an
automatic de-noising mechanism: since the coarse level
coefficients (e.g., the first level coefficients) in DWT
generally contain “contributions” from noise, suppres-
sing coarse level coefficients not only filters unnecessary
global features but also removes the noise. The MICA
algorithm can be described as following steps.
1). Wavelet transforms
Given a gene expression profile with p samples across n
genes Xx x x x np p
T
i
n =∈
× [, ] , , 12
1   ,M I C Ac o n -
ducts a L-level discrete wavelet transform for each sam-
ple to obtain a sequence of detail coefficient matrices
Dn n j L j
np
j
j j ∈=
×  ,~ /, , 21 2and an approxima-
tion coefficient matrix An n L
np
L
L L ∈
×+  ,~ / 2
1,i . e . ,
TD W T X ← () , where TD DD A LL ={, ,} 12  .
2). Feature selection
Al e v e lt h r e s h o l d11 ≤≤−  L is selected to suppress
redundant global features and maintain local features
as follows. If 1 ≤≤ j  , 1) conduct principal compo-
nent analysis for Dj to obtain its PC matrix:
Uu u u u pi
p =∈
× [, ] , 12
1  and the corresponding score
matrix Ss s ss k p pk
n j =∈ = [, ] , , , 12 12   . 2) reconstruct
the original Dj by using the first loading vector u1 in
the PC matrix as Dn Ds u jj j n
T
j ←+ × (/ ) ( ) 11 11

,w h e r e
() 1
1 
 n
n
j
j ∈
× is a vector containing all ‘1’s. If j > ,
reconstruct and update each detail coefficient matrix
Dj by using the loading vectors uu u k 12 ,  with the
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corresponding vectors in the score matrix:
Dn D s s s u u u jj j n n
T
kk
T
jj ←+ × (/ ) ( )( ) [, ][ , ] 11 1 12 12

 .T h e
explained variance percentage is the ratio between the
accumulative variance from the selected data and the
total data variance. For example, the explained var-
iance percentage rr from those first r loading vectors
is defined as   ri
i
r
j
j
p
=
== ∑∑ /
11
,w h e r eli is the data var-
iance from the ith loading vector. In the implementa-
tion, this step can be ‘lazily’ simplified as: keep all
detail coefficient matrices DD D L  ++ 12 ,  intact to
save computing resources.
3). Inverse discrete wavelet transforms
Conduct the corresponding inverse discrete wavelet
transform using the updated coefficient matrices
TD D D A WT L L ={, ,} 12  to get the meta-profile of
X: X
pn * ∈
×  , i.e., XI D W T T WT
* () . ←
4). Independent component analysis
Conduct the classic independent component analysis for
X
* to obtain independent components and the mixing
matrix: XA Z
* = ,w h e r e AZ
pk kn ∈∈
××  , ,a n d
kp n ≤  .
5). Subspace decomposition
The meta-profile X
* is the approximation of the original
profile X by removing the redundant global features and
retaining almost all local features by selecting features
on behalf of their frequencies. It is easy to decompose
each sample in the subspace spanned by all independent
components Ss p a n z z z k *( , ) = 12  . Each independent
component is a basis in the subspace., i.e.,
[, ] [, ] xx x Zaa a p
T
p 12 12  = , where the mixing matrix
is Aa a a a p
T
i
k =∈ [, ] , 12  , and the independent
component matrix is Zz z z z k
T
k
n =∈ [, ] , 12  .I n
other words, each sample can be represented as
xZ a i
T
i = , where the meta-sample ai is the i
th row of
the mixing matrix recording the coordinate values of
the sample xi i nt h es u b s p a c e .A sal o wd i m e n s i o n a l
vector, the meta-sample ai retains almost all local fea-
tures and the most outstanding global features of the
original high-dimensional sample xi. Thus it can be
called as a data-locality preserved prototype of xi.
Figure 1 visualizes three controls and cancers of the
‘breast_1’ data (see Table 1 for more information) and
their meta-samples obtained from MICA at τ = 3,4,6
with a Daubechies family wavelet ‘db8’,w h e r et h ec o n -
trol and cancer samples are indicated by red and blue
lines respectively. Interestingly, extracted local features
and selected important global features make two types
of samples display two distinct prototypes in the low-
dimension subspace. With the increase of the level
thresholds, the two groups of prototypes tend to show
more capabilities to separate cancer and control sam-
ples. Moreover, two types of meta-samples demonstrate
a “self-clustering” mechanism in that the meta-samples
belonging to the same type show close spatial proximi-
ties. Obviously, the clear sample separation information
conveyed by the self-clustering mechanism of the meta-
samples is almost impossible to obtain from the original
high-dimensional data directly, and the key discrimina-
tive features captured by our proposed MICA method
would be able to facilitate the subsequent classification
step and contribute to high-accuracy disease diagnosis.
Multi-resolution Independent component analysis based
support vector machines (MICA-SVM)
The MICA-based support vector machines apply the
classic support vector machines (C-SVM) [10] to the
meta-samples to gain classification information in a low-
dimensional space. Unlike the traditional SVM that builds
a maximum margin hyper-plane in the original data space
ℝ
n where n~10
3-10
4, MICA-SVM separates biological
samples by constructing the maximum margin hyperplane
in the spanned subspace S
k *⊂  where k ≤ p~10
2,
using the meta-samples. If we assume the number
of support vectors Ns is much less than the training
points l, the time complexity of the MICA-SVM is
ON N l N k l k n ss s () ,
32 ++ × ×  , which is much lower
than that of the classic SVM ON N l N n l ss s ()
32 ++ × × ,
provided the same number of training points and support
vectors. We briefly describe the MICA-SVM classifier for
binary classification. Given a training dataset
Xx x x x np p
T
i
n =∈ [, ] , , 12   , and sample class type
information {,} xc ii i
p
=1, where ci ∈− {, } 11 , a meta-dataset
Aa a a a p
T
i
k =∈ [, ] , 12  is computed by using the
multi-resolution independent component analysis. Then, a
maximum margin hyper-plane: Ow ab w h
T
i
k :, += ∈ 0  is
constructed to separate the ‘+1’ (‘cancer’)a n d‘-1’ (‘con-
trol’) types of meta-samples. It is equivalent to solving the
following quadratic programming problem,
min || ||
.. ( ) , , ,
,, wb
i
i
p
i
T
ii i
wC
st c w a b i p



1
2
10 1 2
2
2
1
+
+≥ − ≥ =
= ∑

(1)
A way to solve (1) is through its Lagrangian dual that
is also a quadratic programming problem, where
i ip ,, =12  are dual variables of the primal variables
w and b.
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.. , ,

 

i
i
p
ij i j i
T
j
j
p
i
p
ii i
cca a
st c C i
== = ∑∑ ∑
∑
−
=≤ ≤ =
11 1
1
2
00 1 12 , p
(2)
The normal of the maximum-margin hyperplane is
calculated as wc a iii
i
p
=
= ∑
1
.T h ed e c i s i o nr u l e
fx s i g n c kaa b ii i
i
N
(’ ) ( ( ’ ) ) =+
= ∑ 
1
is used to determine
the class type of a testing sample x′,w h e r eaa i
k ,’ ∈
are the corresponding meta-samples of samples
xx i
n ,’ ∈ , computed from MICA respectively. The
function ky y i (’ )  is a SVM kernel function that maps
these meta-samples into a same-dimensional or high-
dimensional feature space. In this work, we only focus
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Figure 1 Meta-samples constructed from MICA for six original samples (’breast_1 data’). Meta-samples constructed from multi-resolution
independent component analysis for six original samples (three controls and three cancers) in the breast_1 data at the three levels thresholds:
τ =3,4,6 with a wavelet ‘db8’. The low-dimensional meta-samples separate two types of samples clearly in visualization.
Table 1 Six gene-expression microarray profiles
Dataset #Genes #Samples Technology
Stroma 18995 13 inflammatory breast cancers (‘ibc’) + 34 non-inflammatory breast cancers (‘non-ibc’) Oligonucleotide
Breast_1 2000 53 controls + 163 cancers Oligonucleotide
Prostate 12600 59 controls + 77 cancers Oligonucleotide
Glioma 12625 28 glioblastomas + 22 anaplastic oligodendrogliomas Oligonucleotide
HCC 7129 20 early intrahepatic recurrence + 40 non-early intrahepatic recurrence Oligonucleotide
Breast_2 24188 46 samples with distant metastasis within 5 year + 51 samples remain disease-free within 5 years cDNA
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microarray pattern classifications. We will point out in
the discussion section that most SVM-based learning
machines would encounter overfitting under the stan-
dard Gaussian kernel (‘rbf’: radial basis function kernels).
Results
We have performed extensive experiments using six
publicly available gene expression microarray profiles
consisting of five oligonucleotide profiles [11-15] and
one cDNA profile [16], in the experiment. Table 1
includes their detailed information. These profiles are
heterogeneous data generated from different experimen-
tal conditions, different profiling technologies, or even
processed by different preprocessing algorithms. For
example, the stroma, prostate, glioma, and HCC data
only go through basic log2 transforms while the
breast_1 data is a dataset obtained by conducting two-
sample t-tests from an original dataset going through
delicate normalizations [12].
Cross validations
To address our algorithm’s superiority and reproducibil-
ity, we compare it with six comparison algorithms in
terms of average classification rates, sensitivities, and
specificities under the k-fold (k=10) and 100-trial of 50%
holdout cross validations. The classification accuracy in
the i
th classification is the ratio of the correctly classified
testing samples over total testing samples: rt n c
i
ii
() / = ,
and the sensitivity and specificity are defined as the
ratios: r tp tp fn r tn tn fp s
i
p
i () () /( ), /( ) =+ =+ respec-
tively, where tp (tn) is the number of positive (negative)
targets correctly classified, and fp (fn) is the number of
negative (positive) targets incorrectly classified respec-
tively. In the 100-trial of 50% holdout cross validation
(HOCV), all samples in the data set are pooled together
and randomly divided into half to get training and test-
ing data. Such a partition is repeated 100 times to get
100 sets of training and testing datasets. In the k-fold
cross validation, an input dataset is partitioned into k
disjoint equal or approximately equal proportions. One
proportion is used for testing and the other k-1 propor-
tions are used for training alternatively in the total k
rounds of classifications. Compared with pre-specified
training or testing data, the cross validations can
decrease potential biases in algorithm performance
evaluations.
Six comparison algorithms
The existing six comparison algorithms can be categor-
ized into two types. The first type consists of standard
support vector machines (SVM) [10] and linear discri-
minant analysis (LDA) [17], both of which are state-of-
the-art classification algorithms. Especially, SVM is
widely employed in gene expression pattern recognition
for its popularity. The second type consists of four
methods embedding transform-based feature selections
in SVM and LDA: they are support vector machines
with principal component analysis/independent compo-
nent analysis/ nonnegative matrix factorization, and lin-
ear discriminant analysis with principal component
analysis. We refer them as PCA-SVM, ICA-SVM, NMF-
SVM, and PCA-LDA conveniently and their related
implementation information can be found in Additional
file 1.
We employ the wavelet ‘db8’ to conduct a 12-level
discrete wavelet transform for each data set, and select a
level threshold τ = 3 in MICA for all profiles. Although
not an optimal level threshold for all data, it guarantees
automatic de-noising and ‘fair’ algorithm comparisons.
Moreover, we have found that the meta-samples
obtained from MICA at τ = 3 can clearly distinguish
two types of samples. Although other level threshold
selections may be possible, any too ‘coarse’ (e.g.τ = 1) or
too ‘fine’ (e.g.τ ≥ 9) level threshold selection may miss
some important global or local features and affect fol-
lowing classifications.
Table 2 and Table 3 illustrate the average performance
of the seven algorithms in terms of the classification
rates, sensitivities, specificities and their standard devia-
tions under the two types of cross validations respec-
tively. The results of LDA are not included in the two
tables for its worst performance. Similarly, the NMF-
SVM and ICA-SVM algorithms are excluded from
Table 3 for their relatively low performance and high
instabilities. Clearly, the proposed MICA-SVM algo-
rithm demonstrates exceptionally leading advantages
over its peers in the three classification performance sta-
tistics for all datasets. For example, it achieves 98.26%,
99.04%, 99.69%, 98.76%, 98.30% and 97.23% average
classification rates on the stroma, breast_1, prostate,
glioma, HCC, and breast_2 data respectively under the
100 trials of 50% HOCV. In addition, MICA-SVM
achieves 98.00%, 99.52%, 100.0%, 100.0%, 100.0%, and
99.00% for the stroma, breast_1, prostate, glioma, HCC,
and breast_2 data respectively under the 10-fold CV. All
these results indicate that MICA can effectively capture
global/local features as well as eliminate the noisy fea-
tures so that SVM can perform significantly better than
the state-of-the-arts. Furthermore, unlike the other
methods that display instabilities in classifications, our
proposed MICA-SVM algorithm demonstrates a strong
stability in attaining high-accuracy detections for all pro-
files. This observation is also supported by its lower
standard deviations of the three classification measures
than those of the others.
Figure 2 compares the distributions of the classifica-
tion rates of the four algorithms on the other five
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obvious that the distributions of classification rates,
sensitivities and specificities of MICA-SVM on these
data are significantly different from those of the other
three peers. Moreover, it seems that there is no statis-
tically significant improvement between SVM and its
feature-selection based extensions: ICA-SVM, PCA-
SVM, and NMF-SVM, because they achieved the same
or slightly lower performance than the standard SVM.
The reason for this is rooted in the global feature
selection mechanisms of the PCA, ICA, and NMF
methods: since biological samples may display very
similar global-characteristics and different local-charac-
teristics in their gene expressions, a classification algo-
rithm (e.g., SVM) integrated with the global-feature
selection methods will inevitably encounter difficulty
Table 2 Algorithm average performance comparisons (100 trials of 50% HOCV)
Dataset Avg. classification rate ±std (%) Avg. sensitivity ± std (%) Avg. specificity ± std (%)
Stroma
mica-svm 98.26±02.25 100.0±00.00 93.89±08.11
svm 73.83±07.02 92.87±06.58 25.45±15.92
pca-svm 71.83±06.78 90.20±08.66 25.62±16.48
ica-svm 71.48±06.78 90.04±09.05 25.06±17.87
nmf-svm 68.39±08.67 86.30±11.93 23.69±11.93
pca-lda 71.35±06.97 89.12±09.15 26.69±17.05
Breast_1
mica-svm 99.04±00.99 99.49±01.18 97.73±02.95
svm 86.40±02.87 92.43±02.76 68.78±11.53
pca-svm 86.19±02.97 92.79±02.68 66.85±11.77
ica-svm 86.27±02.99 92.80±02.82 67.11±12.37
nmf-svm 85.44±02.42 93.52±02.91 61.29±09.10
pca-lda 86.25±02.89 92.43±02.83 68.15±11.95
Prostate
mica-svm 99.69±00.67 99.88±00.64 99.44±01.38
svm 91.16±02.58 89.53±04.53 93.42±04.57
pca-svm 90.76±02.65 89.18±04.60 92.94±04.76
ica-svm 61.43±08.54 78.75±23.15 41.09±28.88
nmf-svm 71.03± 07.27 88.48±07.17 49.84±19.33
pca-lda 90.47±03.46 89.46±04.81 91.87±05.76
Glioma
mica-svm 98.76±02.03 98.89±02.90 98.82±02.89
svm 74.00±07.51 68.19±12.71 79.45±11.30
pca-svm 72.60±06.81 69.05±14.38 76.25±11.69
ica-svm 47.20±08.79 25.24±29.21 69.61±29.55
nmf-svm 74.40±08.04 74.53±11.10 74.19±13.53
pca-lda 73.96±07.02 68.38±12.41 79.18±12.39
HCC
mica-svm 98.30±02.30 99.23±02.02 96.97±06.05
svm 61.53±07.75 75.04±12.40 37.15±18.27
pca-svm 60.93±07.90 72.82±14.19 39.53±17.70
ica-svm 58.73±07.29 72.37±12.51 29.72±15.93
nmf-svm 61.30±08.91 71.17±13.47 43.47±16.67
pca-lda 61.07±07.58 74.15±12.40 37.15±17.08
Breast_2
mica-svm 97.23±03.20 97.79±03.90 96.93±05.17
svm 63.04±05.48 65.81±11.20 61.59±13.17
pca-svm 62.29±05.54 66.86±12.09 59.00±13.72
ica-svm 62.27±05.59 67.39±11.51 58.28±13.81
nmf-svm 62.77±06.60 66.92±10.68 59.57±13.69
pca-lda 62.54±05.48 66.94±11.90 59.39±13.25
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Page 7 of 14in distinguishing these samples. Although extracted by
different transform methods, the global features statis-
tically have almost same level contributions to the pat-
tern classifications of a data set. Moreover, the
redundant global features brought by the global feature
selection mechanism may be involved in the follow-
ing SVM learning, which limits all the SVM exten-
sions’ generalization and causes their instabilities in
classification. However, the local feature capturing
and redundant global feature suppressing mechanism
in MICA not only attains much better performance
than the standard SVM but also maintains algorithm
stability in classification. Moreover, Figure 3 shows
the MICA-SVM’s leading advantages over the other
four peers on behalf of the average classification
rates, sensitivities, specificities, and positive predic-
tion ratios under the 10-fold cross validations. All
the results directly demonstrate the superiority of
MICA to the three general global feature selection
algorithms.
Multi-resolution independent component analysis based
linear discriminant analysis
We also apply MICA to linear discriminant analysis
(LDA) to further explore its effectiveness. Similar to the
MICA-SVM algorithm, the MICA-based linear discrimi-
nant analysis (MICA-LDA) applies the classic LDA to the
meta-samples obtained from MICA to gain sample classi-
fications (We skip the detailed algorithm description on
MICA-LDA for the space constraint). The MICA-LDA
algorithm’s performance on the six profiles can be found
in the Additional file 2. To keep consistency with the pre-
vious experiments, we still employ the ‘db8’ wavelet and
set the level threshold τ = 3 in MICA. Interestingly, the
MICA-LDA classifier is only secondary to the MICA-
SVM classifier: it outperforms the other comparison
algorithms on the five datasets except the prostate data
in terms of the average performance under the 100 trials
of HOCV and 10-fold CV. This further indicates that
MICA’s effective feature selection and its contribution to
subsequent classification methods. Figure 4 compares the
Table 3 Algorithm average performance comparisons (10-fold CV)
Dataset Avg. classification rate ± std (%) Avg. sensitivity ± std (%) Avg. specificity ± std (%)
Stroma
mica-svm 98.00 ± 06.32 100.0 ± 00.00 95.00 ± 15.81
pca-lda 71.83 ± 11.15 94.17 ± 12.45 15.00 ± 33.75
svm 74.83 ± 19.76 90.83 ± 14.93 35.00 ± 47.43
pca-svm 71.00 ± 16.47 91.67 ± 18.00 15.00 ± 33.75
Breast_1
mica-svm 99.52 ± 01.51 100.0 ± 00.00 98.00 ± 06.32
pca-lda 88.51 ± 06.10 90.88 ± 07.60 81.00 ± 15.56
svm 87.49 ± 06.85 91.91 ± 08.37 75.00 ± 22.62
pca-svm 88.00 ± 04.99 91.47 ± 05.81 77.00 ± 15.27
Prostate
mica-svm 100.0 ± 00.00 100.0 ± 00.00 100.0 ± 00.00
pca-lda 93.29 ± 05.50 90.71 ± 08.74 96.67 ± 07.03
svm 94.12 ± 05.84 92.32 ± 06.63 96.33 ± 07.77
pca-svm 93.35 ± 05.48 92.32 ± 08.87 95.00 ± 08.05
Glioma
mica-svm 100.0 ± 00.00 100.0 ± 00.00 100.0 ± 00.00
pca-lda 76.33 ± 18.93 68.33 ± 36.39 81.67 ± 19.95
svm 75.67 ± 19.82 66.67 ± 33.33 81.67 ± 19.95
pca-svm 78.00 ± 17.98 68.33 ± 27.72 86.67 ± 17.21
HCC
mica-svm 100.0 ± 00.00 100.0 ± 00.00 100.0 ± 00.00
pca-lda 68.33 ± 14.59 80.00 ± 15.81 45.00 ± 43.78
svm 71.67 ± 15.81 82.50 ± 16.87 50.00 ± 33.33
pca-svm 63.33 ± 17.21 77.50 ± 14.19 35.00 ± 33.75
Breast_2
mica-svm 99.00 ± 03.16 100.0 ± 00.00 98.00 ± 06.32
pca-lda 62.77 ± 20.39 59.33 ± 19.74 66.50 ± 28.87
svm 67.61 ± 17.41 66.33 ± 25.26 69.00 ± 29.89
pca-svm 62.94 ± 13.09 60.67 ± 23.19 65.00 ± 22.36
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Page 8 of 14distribution of classification rates from the three LDA-
based algorithms: MICA-LDA, PCA-LDA, and LDA on
four data sets under the 100 trials of 50% HOCV. Inter-
estingly, MICA-LDA obviously outperforms PCA-LDA
and LDA by its right-skewed classification rate distribu-
tions. Although PCA-LDA also demonstrates classifica-
tion advantages over LDA, MICA-LDA has attained
much more impressive improvements than PCA-LDA.
On the other hand, this also indicates that the multi-
resolution independent component analysis is more
effective in the feature selection than principal compo-
nent analysis, which contributes directly to improving
LDA classifier’s performance.
Optimal level threshold selections
A remaining question is how to determine the optimal
level threshold in MICA so that the following SVM clas-
sifier achieves best performance. We employ the condi-
tion number  = ss max min / of the independent
component matrix Z in MICA to resolve it, where Smax
and Smin are the maximum and minimum singular
values of the matrix Z calculated from MICA. A smaller
c o n d i t i o nn u m b e ri n d i c a t e sam o r es t a b l em a t r i xt h a t
suggests a better status in glo b a la n dl o c a lf e a t u r ec a p -
turing. The level-threshold is counted ‘optimal’ if the
condition number δ is the smallest. If the condition
numbers from two level thresholds are same numeri-
cally, the lower level threshold (which is required to be
> 1) is counted as the optimal one. For example, the
smallest δ value is achieved at τ = 6a n dτ = 7,8,9,10,11
respectively on the HCC data. We choose τ = 6a st h e
optimal threshold which is corresponding to the best
average the average classification rate: 98.77% (STD:
2.26%) with average sensitivity: 99.44% (±2.11%) and
specificity are 97.59% (±4.97%) respectively.
Figure 5 shows the MICA-SVM average classification
rates and corresponding condition number δ values
under the 100 trials of 50% HOCV on the ‘stroma’,
‘breast_1’,a n d‘breast_2’,a n d‘HCC’ data, as the level
threshold values in MICA are selected from 1 to 11.
Obviously, the optimal level threshold can be identified
by finding the level threshold corresponding to the
minimum condition number. Although the optimal
threshold at τ = 8 corresponding to average classification
rate 99.11% (±0.89%), which is slightly lower than the
actual best average classification rate: 99.20% (±0.92%)
achieved at τ = 6, it is ignorable due to possible numeri-
cal inaccuracy from the fixed point iteration in MICA.
Furthermore, we have found that MICA-SVM has rela-
tively low-level performance at too coarse level thresh-
olds (e.g. τ = 1). Although δ values and MICA-SVM
performance show some-level stability under some fine
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Page 9 of 14level thresholds, too fine level thresholds (e.g. τ ≥ 8)
may decrease classification performance on some data
(e.g., stroma data). Also, the optimal level threshold
selection method may bring some computing overhead
in practical classification. In practice, we suggest the
empirical level threshold as 22 ≤≤ ⎡ ⎢ ⎤ ⎥  L / for its rela-
tive robust performance and automatic de-noising
property.
Although only wavelet ‘db8’ is employed in our
experiments, there is no other specific requirement in
M I C A - S V Mf o raw a v e l e te x c e p ti ts h o u l db eo r t h o g o -
nal. To compare effects of different wavelet selections
on the algorithm performance, we select four family
wavelets: ‘db8’, ‘sym8’, ‘coif4’, and ‘bior4.4’, in the classifi-
cations on the six profiles at the level threshold τ = 3. It
seems that there is no obvious classification advantage
from one wavelet over the other under the 10-fold CV,
because the robust prior knowledge and less number of
trials may have larger impact factors on the algorithm
performance than a wavelet selection. However, we have
found that the wavelet ‘db8’ show some advantages over
the others under the 100 trials of 50% HOCV. In addi-
tion, it is interesting to see that the wavelets ‘coif4’ and
‘sym8’ have almost same-level performance, but the
wavelet ‘bior4.4’ has a relatively low performance for the
six profiles.
We further demonstrate the superiority of MICA-
SVM by comparing it with three state-of-the-art partial
least square (PLS) based regression methods, which can
be found in the Additional file 3. Moreover, we present
a novel algorithm stability analysis for the seven classifi-
cations and show the advantages of the MICA-SVM and
MICA-LDA algorithms over the others (Please see the
Additional file 4 for details).
MICA-based biomarker discovery
In addition to classifying large scale heterogeneous
tumor profiles with exceptional performance, multi-
resolution independent component analysis can be also
applied to capture biomarkers for microarray profiles.
We present a MICA-based filter-wrapper biomarker
capturing algorithm and apply it to the stroma data.
The details of this algorithm can be found in the Addi-
tional file 5. Table 4 lists the details on all the three bio-
markers captured, where the SVM-rate for each
biomarker is the classification ratio achieved by a SVM
classifier with the ‘rbf’ kernel on the biomarker under
leave-one-out cross validations. The order of the three
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Page 11 of 14biomarkers in Table 4 is listed according to its order
identified in the biomarker discovery process. The SVM
accuracy under the three biomarkers is 97.87% and the
corresponding sensitivity and specificity are 92.31% and
100% respectively. The first biomarker is gene USP46,
which is a broadly expressed gene reported as one gene
associated with breast cancer and glioblastomas [18].
The second biomarker is FOSL2, which is one of four
members in the Fos gene family. It is responsible for
encoding leucine zipper proteins, which is able to
dimerize with proteins of the JUN family, and form the
transcription factor complex AP-1. As a regulator in cell
proliferation, differentiation, and transformation, recent
studies [19,20] have showed that it is one of important
genes associated with breast cancer, by being involved
in the regulation of breast cancer invasion and metasta-
sis. The third biomarker is gene RPL5, which encodes a
ribosomal protein that catalyzes protein synthesis. It was
reported to associate with biosynthesis and energy
utilization that is a cellular function associated with
pathogenesis of breast cancer [21]. In addition, it also
links to the breast cancer by lowering MDM2, which is
a major regulator of p53 levels, preventing p53 ubiquiti-
nation and increasing its transcriptional activity [22].
Figure 6 visualizes the 47 samples (13 inflammatory
breast cancers (’ibc’) and 34 non-inflammatory breast
cancers (’non-ibc’)) of the stroma data using the three
biomarkers. It is interesting to see that two types of can-
cers are separated into two spatially disjoint sets clearly,
though one ‘ibc’ sample is wired in the ‘non-ibc’
samples.
Discussion
It is worthy to note that independent component analy-
sis is a necessary step to achieve a good classification
performance. A similar multi-resolution principal com-
ponent analysis based SVM algorithm is not able to
reach comparable performance as our algorithm because
Table 4 Three biomarkers discovered for the stroma data
Gene Description Bayes
Factors
SVM-
rates
MICA-
coefficients
USP46 It belongs to a large family of cysteine proteases that function as deubiquitinating enzymes. 0.0093 0.8936 63.1453
FOSL2 It encodes leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming
the transcription factor complex AP-1.
0.0418 0.8085 79.8313
RPL5 It encodes a ribosomal protein that catalyzes protein synthesis. It can lower MDM2 and prevent
preventing p53 ubiquitination and increase its transcriptional activity.
0.5056 0.5957 81.8651
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Figure 6 Biomarker visualization in the stroma data. Visualization of 47 samples in the stroma data by using three biomarkers.
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Page 12 of 14of the loss of statistical independence in the feature
selection. Also, MICA-SVM encounters overfitting as
SVM, PCA-SVM, ICA-SVM classifiers under the stan-
dard Gaussian kernel (‘rbf’), where each learning
machine can only recognize the majority type samples
of the training data in classification despite the testing
sample type. Moreover, we have tried kernel ICA [23]
based support vector machines (KICA-SVM) in our
experiments in addition to the previous nine compari-
son algorithms. However, The KICA-SVM classifier gen-
erally has a lower performance level than the standard
SVM classifier. Furthermore, the KICA-SVM not only
shows a strong instability in classification but also inevi-
tably encounters overfitting under the standard Gaussian
kernel like the other learning machines. It seems to sug-
gest that kernel based data reduction may not be a
desirable approach in effective feature selection for high
dimensional heterogeneous gene profiles. Similar results
can be also found in kernel PCA [24] based support vec-
tor machine (KPCA-SVM) classifications: a KPCA-SVM
classifier is essentially the PCA-SVM classifier when its
two kernels are selected as ‘linear’, otherwise, it encoun-
ters overfitting under the standard Gaussian kernel. In
our ongoing project, in addition to further polishing our
algorithm by comparing them with other state-of-the-art
methods (e.g., SVM-RFE [2]), we are interested in theo-
retically validating the MICA-SVM‘sa d v a n t a g e so v e r
the classic SVM classifier from the viewpoint of
Vapnik–Chervonenkis (VC) dimension theory [10].
Conclusions
In this study, we present a novel multi-resolution feature
selection algorithm: multi-resolution independent compo-
nent analysis for effective feature selection for high-
dimensional heterogeneous gene expression profiles,
propose a high-performance MICA-SVM classification
algorithm, and demonstrate its superiority and stability
by comparing it with the nine state-of-the-art algorithms.
Our algorithm not only consistently demonstrates the
high-accuracy or clinical-level cancer diagnosis by treat-
ing an input profile a whole biomarker but also shows
effectiveness in meaningful biomarker discovery. It sug-
gests a great potential to facilitate high-throughput
microarray technology into a clinical routine, especially,
current classification methods have relative low even
poor performance on the gene expression data. In addi-
tion, the multi-resolution data analysis based redundant
global feature suppressing and effective local feature
extraction will have a positive impact on large scale
‘omics’ data mining. In our future work, we plan to
further explore MICA-SVM’s potential in other platform
gene expression data, SNP, and protein expression data
classification.
Additional material
Additional file 1: Implementations of the four comparison
algorithms PCA-LDA, PCA-SVM, ICA-SVM, and NMF-SVM algorithm
implementations
Additional file 2: MICA-LDA performance MICA-LDA performance
under 100 trials of 50% HOCV and 10-fold CV
Additional file 3: Comparing MICA-SVM with PLS-based regression
methods Comparisons MICA-SVM with three partial least square (PLS)
based regression methods
Additional file 4: Algorithmic stability analysis
Additional file 5: MICA-based biomarker discovery algorithms
Acknowledgements
The authors want to thank three anonymous reviewers for their valuable
comments in improving this manuscript.
This article has been published as part of BMC Bioinformatics Volume 12
Supplement 1, 2011: Selected articles from the Ninth Asia Pacific
Bioinformatics Conference (APBC 2011). The full contents of the supplement
are available online at http://www.biomedcentral.com/1471-2105/12?
issue=S1.
Author details
1Center for Computational Medicine and Bioinformatics, University of
Michigan, Ann Arbor MI 48109, USA.
2Departament of Mathematics and
Bioinformatics, Eastern Michigan University, Ypsilanti MI 48197, USA.
3Institute
for Infocomm Research, Agency for Science, Technology and Research
(A*STAR), Singapore 138632.
Authors’ contributions
HEY collects and processes the data, designs algorithms, implements the
methods, and drafts paper. LXL participates in discussion and provides help
to polish the paper. HEY and LXL jointly finalize the paper.
Competing interests
The authors declare that they have no competing interests.
Published: 15 February 2011
References
1. Wang Y, Klijn J, Zhang , Atkins , Foeken J: Gene expression profiles and
prognostic markers for primary breast cancer. Methods Mol Biol 2007,
377:131-138.
2. Zhou X, Tuc D: MSVM-RFE: extensions of SVM-RFE for multiclass gene
selection on DNA microarray data. Bioinformatics 2007, 23(9):1106-1114.
3. Jolliffe I: Principal component analysis Springer Series in Statistics, 2nd ed.,
Springer, New York; 2002.
4. Hyvärinen A: Fast and robust fixed-point algorithms for independent
component analysis. IEEE Transactions on Neural Networks 1999,
10(3):626-634.
5. Lee D, Seung H: Learning the parts of objects by non-negative matrix
factorization. Nature 1999, 401:788-791.
6. Brunet J, Tamayo P, Golub T, Mesirov J: Molecular pattern discovery using
matrix factorization. Proc Natl Acad Sci U S A 2004, 101(12):4164-4169.
7. Gao Y, Church G: Improving molecular cancer class discovery through
sparse nonnegative matrix factorization. Bioinformatics 2005,
21(21):3970-3975.
8. Han X: Nonnegative Principal component Analysis for Cancer Molecular
Pattern Discovery. IEEE/ACM Trans Comput Biol Bioinform 2010,
7(3):537-549.
9. Mallat S: A wavelet tour of signal processing Acad. Press, San Diego; 1999.
10. Vapnik V: Statistical Learning Theory John Wiley & Son, Inc., New York;
1998.
11. Boersma BJ, Reimers M, Yi M, Ludwig J, et al: A stromal gene signature
associated with inflammatory breast cancer. Int J Cancer 2008, 15(122
(6)):1324-1332.
Han and Li BMC Bioinformatics 2011, 12(Suppl 1):S7
http://www.biomedcentral.com/1471-2105/12/S1/S7
Page 13 of 1412. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, et al: Gene-expression
profiles to predict distant metastasis of lymph-node-negative primary
breast cancer. Lancet 2005, 25(365(9460)):671-679.
13. Singh D, Febbo P, Ross K, Jackson D, Manola J, Ladd C, et al: Gene
expression correlates of clinical prostate cancer behavior. Cancer Cell
2002, 1(2):203-209.
14. Nutt CL, Mani D, Betensky R, Tamayo P, Cairncross J, et al: Gene
expression-based classification of malignant gliomas correlates better
with survival than histological classification. Cancer Research 2003,
63(7):1602-1607.
15. Iizuka N, Oka M, Yamada-Okabe H, Nishida M, Maeda Y, et al:
Oligonucleotide microarray for prediction of early intrahepatic
recurrence of hepatocellular carcinoma after curative resection. Lancet
2003, 361:923-929.
16. van’t Veer L, Dai H, Van De Vijver M, He Y, et al: Gene Expression Profiling
Predicts Clinical Outcome of Breast Cancer. Nature 2002, 415:530-536.
17. Martinez A, Kak A: PCA versus LDA. IEEE Transactions on Pattern Analysis
and Machine Intelligence 2001, 23(2):228-233.
18. Holtkamp N, Ziegenhagen N, Malzer E, Hartman C, Giese A, et al:
Characterization of the amplicon on chromosomal segment 4q12 in
glioblastoma multiforme. Neuro Oncol 2007, 9(3):291-297.
19. Milde-Langosch K, Janke S, Wagner I, Schroder C, Streichert T, et al: Role of
Fra-2 in breast cancer: influence on tumor cell invasion and motility.
Breast Cancer Res Treat 2008, 107(3):337-47.
20. Langer S, Singer CF, Hudelist G, Dampier B, Kaserer K, et al: Jun and Fos
family protein expression in human breast cancer: correlation of protein
expression and clinicopathological parameters. Eur J Gynaecol Oncol 2006,
27(4):345-52.
21. Yu K, Lee C, Tan PH, Tan P: Conservation of Breast Cancer Molecular
Subtypes and Transcriptional Patterns of Tumor Progression Across
Distinct Ethnic Populations. Clinical Cancer Research 2004, 10:5508-5517.
22. Lacroix M, Toillon R, Leclercq G: p53 and breast cancer, an update.
Endocrine-Related Cancer 2006, 13(2):293-325.
23. Bach F, Jordan M: Kernel independent component analysis. Journal of
Machine Learning and Research 2002, 3:1-48.
24. Schölkopf B, Smola A, Müller K: Nonlinear component analysis as a kernel
eigenvalue problem. Neural Computation 1998, 10:1299-1319.
doi:10.1186/1471-2105-12-S1-S7
Cite this article as: Han and Li: Multi-resolution independent
component analysis for high-performance tumor classification and
biomarker discovery. BMC Bioinformatics 2011 12(Suppl 1):S7.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Han and Li BMC Bioinformatics 2011, 12(Suppl 1):S7
http://www.biomedcentral.com/1471-2105/12/S1/S7
Page 14 of 14